Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Forest Acquiring Clinical Data for $1.2B

February 22, 2011 5:55 am | News | Comments

Forest Laboratories Inc. said it is buying specialty pharmaceutical company Clinical Data Inc. in a $1.2 billion deal in order to gain access to a key antidepressant.


Automated Colony Counting

February 18, 2011 7:28 am | Product Releases | Comments

Synbiosis, a leading manufacturer of automated microbiological systems, will debut its ProtoCOL 2 automated colony counting and zone measurement system for quick and easy analysis of standard and large plates at ArabLab 2011.


Water Analyzers

February 18, 2011 7:24 am | Product Releases | Comments

Shimadzu Scientific Instruments introduces the TOC-L Series of analyzers for total organic carbon testing in aqueous samples. With a wide sample range from 4 ?g/L to 30,000 mg/L, the TOC-L is suitable for analyzing ultra-pure to highly contaminated samples of pharmaceutical water.


Researchers Find New Breast Cancer Oncogene

February 18, 2011 7:06 am | News | Comments

Scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop. This is the first time in over five years that scientists have discovered a new breast cancer "oncogene".


Expectation Bubble Could Hurt Genomics

February 18, 2011 6:50 am | News | Comments

Unrealistic expectations about genomic medicine have created a "bubble" that needs deflating before it puts the field's long term benefits at risk, four policy experts write in the current issue of the journal Science.


Exploring EGFR Signaling

February 18, 2011 6:45 am | by Rick Wiese, PhD, R&D Manager; EMD Millipore, Billerica, Mass. | Articles | Comments

The ErbB, or epidermal growth factor receptor, tyrosine kinase family plays a crucial role in regulating cell proliferation, differentiation, motility, and apoptosis, which contribute to pathological processes such as cancer.


FDA Approves ABILIFY for Bipolar Disorder

February 18, 2011 6:34 am | News | Comments

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration has approved ABILIFY as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of bipolar I disorder.


CHMP Gives Nod to Rasilamlo

February 18, 2011 6:23 am | News | Comments

Swiss drugmaker Novartis said a European advisory committee gave a positive recommendation for its blood pressure treatment Rasilamlo. The pill aims to treat high blood pressure that is not adequately controlled by either aliskiren or amlodipine alone.


Almac Debuts Bioinformatics Consultancy Arm

February 18, 2011 6:21 am | News | Comments

Almac’s newly launched Bioinformatics consultancy supports discovery and development of biomarkers as well as enabling an in-depth understanding of biology by partnering with customers in the pharmaceutical, biotech, and diagnostics setting.


AstraZeneca Provides $500K to WV Clinics

February 18, 2011 6:13 am | by Brittany Erskine | News | Comments

West Virginia Health Right has received a three-year grant worth $556,957 to fund a healthy heart program for its 34-county coverage area, officials announced.


GE Healthcare Appoints New Life Science CEO

February 18, 2011 6:08 am | News | Comments

GE Healthcare announced that on April 1, 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31, 2011.


Year in Jail for BMS Thief

February 18, 2011 5:58 am | News | Comments

A fired employee who admitted stealing trade secrets from Bristol-Myers Squibb Co. in a plot to launch a pharmaceutical business in his native India has been sentenced to a year he's already served in jail in upstate New York.


Seeing More Sensitivity in SFC

February 18, 2011 5:25 am | by Mike May, PhD, Contributing Editor | Articles | Comments

Supercritical fluid chromatography has begun taking on new roles in the pharmaceutical industry.


Two Is Better Than One

February 18, 2011 5:11 am | by Ted Agres, Contributing Editor | Articles | Comments

Joint development of investigational drugs could speed combination drugs to market, if legal issues don’t overwhelm scientific challenges.


Simulating with Software

February 18, 2011 4:39 am | by Mike May, Contributing Editor | Articles | Comments

From quantum mechanical techniques to docking algorithms, drug discovery grows increasingly dependent on molecular modeling.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.